WIfI 3-4期患者伤口愈合、无伤口生存期与无截肢生存分析
该两中心回顾性研究纳入920例WIfI 3-4期慢性肢体威胁性缺血患者(1091条肢体),分析1158个伤口事件,中位随访29.0个月。结果显示仅47.6%伤口愈合,中位愈合时间248天,血运重建与愈合独立相关,但愈合后无伤口生存期在各治疗策略间无差异。
要点
- WIfI 3-4期慢性肢体威胁性缺血患者伤口愈合率不足一半,中位愈合时间超过6个月。
- 成功血运重建与伤口愈合可能性独立相关(HR 2.45),但未缩短中位愈合时间。
- 一旦伤口愈合,无伤口生存期在各治疗策略间无显著差异。
核心结论
- 在高风险慢性肢体威胁性缺血(WIfI 3-4期)患者中,伤口愈合时间长(>6个月),且不足一半的伤口事件实现愈合。
- 血运重建与伤口愈合强烈相关,但愈合后的无伤口生存期在不同治疗策略间相似。
- 以伤口为中心的指标(愈合时间和无伤口生存期)可补充传统生存终点。
研究设计与样本
- 两中心回顾性分析,纳入9年间1483例慢性肢体威胁性缺血患者中的920例WIfI 3-4期患者(1091条肢体),共1158个伤口事件。
- 中位随访29.0个月(四分位距10.0-45.0个月),治疗方式包括血管腔内(62%)、开放(17%)、杂交(3%)和仅伤口护理(18.4%)。
主要发现
- 总体550个伤口事件(47.6%)愈合,中位伤口愈合时间248天(四分位距120-441天)。
- 成功血运重建与愈合独立相关(校正比值比2.45;95%置信区间1.71-3.50;P<.001)。
- 愈合的独立预测因素包括成功血运重建(风险比2.45;95%置信区间1.71-3.50;P<.001)、肥胖(风险比1.52;P=.003)和高脂血症(风险比1.55;P=.044),而WIfI 4期预测愈合降低(风险比0.61;P<.001)。
- 550个愈合事件中79个(14.4%)在中位502天(四分位距163-1084天)出现复发或接受大截肢,中位无伤口生存期502天(95%置信区间350-654天),Kaplan-Meier分析示不同治疗策略间无差异(P=.41)。
- 末次随访时720例患者(62.2%)发生大截肢或死亡,仅伤口护理组1年保肢率、生存率和无截肢生存率 consistently 较低。
临床怎么用
- 对WIfI 3-4期患者应预期伤口愈合时间较长(>6个月),需强化伤口护理和随访。
- 成功血运重建可提高伤口愈合可能性,应作为综合治疗的重要组成部分。
- 评估疗效时除传统生存终点外,可考虑采用伤口愈合时间和无伤口生存期作为补充指标。
局限性
- 回顾性研究设计可能引入选择偏倚和混杂因素。
- 仅纳入两中心数据,外推性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent publications in low-risk Wound, Ischemia, and foot Infection (WIfI) stage 1 to 2 chronic limb-threatening ischemia (CLTI) suggest wound care-first strategies are safe. Although revascularization is widely accepted as beneficial in high-risk WIfI stage 3 to 4 patients, its impact on wound-centered outcomes such as wound healing time (WHT) and wound-free period (WFP) has not been well-characterized. METHODS: A two-center, retrospective analysis was performed. Baseline data included demographics, comorbidities, perfusion indices, WIfI, and treatment modality (endovascular, open, hybrid, wound care only). Outcomes were WHT, WFP, and amputation-free survival. WHT was defined as the interval from initial presentation to complete epithelialization, regardless of interim reinterventions; major amputation or death prior to healing were classified as unhealed episodes. WFP was defined as the healed interval until recurrence or censoring. RESULTS: Over 9 years, 1483 patients were managed with CLTI, of whom 920 (1091 limbs) were WIfI stage 3 and 4 disease. These contributed 1158 wounds episodes (median follow-up, 29.0 months; interquartile range [IQR], 10.0-45.0 months). Most limbs underwent revascularization (n = 945; 81.6%), including endovascular (n = 713; 62%), open (n = 196; 17%), and hybrid (n = 36; 3%) approaches, whereas 18.4% were managed with wound care only. Overall, 550 wound episodes (47.6%) healed, with a median WHT of 248 days (IQR, 120-441 days). The median WHT did not differ meaningfully by revascularization strategy. Successful revascularization was independently associated with a higher likelihood of healing (adjusted odds ratio, 2.45; 95% confidence interval [CI], 1.71-3.50). Independent predictors of healing included successful revascularization (hazard ratio [HR], 2.45; 95% CI, 1.71-3.50; P < .001), obesity (HR, 1.52; P = .003), and hyperlipidemia (HR, 1.55; P = .044), whereas WIfI stage 4 predicted decreased healing (HR, 0.61; P < .001). Among 550 healed episodes, 79 (14.4%) developed recurrence or underwent major amputation at a median of 502 days (IQR, 163-1084 days). The median WFP was 502 days (95% CI, 350-654 days) and did not differ by treatment strategy on Kaplan-Meier analysis (P = .41). At last follow-up, 720 patients (62.2%) experienced major amputation/death. One-year limb salvage, survival, and amputation-free survival were consistently lower in the wound care-only group, whereas revascularized patients demonstrated more favorable early outcomes. CONCLUSIONS: In high-risk CLTI (WIfI 3-4), wound healing is prolonged (>6 months), and fewer than one-half of wound episodes heal. Revascularization was strongly associated with wound healing. Once healing occurred, durability (WFP) was similar across strategies. These findings highlight the value of wound-centered metrics (WHT and WFP) to complement traditional survival-based endpoints in this population.
引用
- Koksoy C, Browder S, Torres Ruiz I, et al. Wound healing, wound-free period and amputation-free survival in patients with Wound, Ischemia, and foot Infection (WIfI) stage 3 and 4 disease. J Vasc Surg. 2026. PMID: 41967734. doi:10.1016/j.jvs.2026.03.625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。